This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

EUS-CPN: A Retrospective Review

This study has been completed.
Information provided by:
Indiana University Identifier:
First received: December 19, 2007
Last updated: September 11, 2012
Last verified: September 2012
The purpose of this retrospective study is to measure the safety of EUS-CPN in patients that have undergone this procedure in the last decade.

Pancreatic Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN): A Retrospective Review of Safety

Resource links provided by NLM:

Further study details as provided by Indiana University:

Primary Outcome Measures:
  • Number of EUS-CPN procedures for each patient [ Time Frame: over a ten year period ]

Secondary Outcome Measures:
  • Procedure-related complications [ Time Frame: over a ten year period ]

Study Start Date: July 2006
Study Completion Date: December 2007

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients that underwent a EUS-CPN over a ten year period at Indiana University Medical Center will be considered.

Inclusion Criteria:

  • Any subject that has undergone EUS-CPN will be considered for this study.

Exclusion Criteria:

  • Subjects will be excluded if they have undergone a celiac plexus neurolysis (endoscopic, percutaneous, or surgical) at an another institution.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00577564

United States, Indiana
Clarian: University Hospital
Indianpolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
Principal Investigator: Julia LeBlanc, MD, MPH Indiana University School of Medicine
  More Information

Responsible Party: Dr. Julia LeBlanc, Indiana University Medical Center Identifier: NCT00577564     History of Changes
Other Study ID Numbers: 0606-59
IRB #0606-59
Study First Received: December 19, 2007
Last Updated: September 11, 2012

Additional relevant MeSH terms:
Pancreatic Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Endocrine Gland Neoplasms
Digestive System Diseases
Pancreatic Diseases
Endocrine System Diseases processed this record on August 17, 2017